financetom
Business
financetom
/
Business
/
Pharvaris Says EU Orphan Designation Received for Deucrictibant
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pharvaris Says EU Orphan Designation Received for Deucrictibant
Apr 1, 2025 5:28 AM

08:06 AM EDT, 04/01/2025 (MT Newswires) -- Pharvaris ( PHVS ) said Tuesday the European Commission has offered orphan designation to deucrictibant, the company's investigational drug to treat bradykinin-mediated angioedema.

In March 2022, deucrictibant received the US Food and Drug Administration's orphan drug designation to treat bradykinin-mediated angioedema, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Axogen Insider Sold Shares Worth $1,246,717, According to a Recent SEC Filing
Axogen Insider Sold Shares Worth $1,246,717, According to a Recent SEC Filing
Oct 31, 2025
04:12 PM EDT, 10/31/2025 (MT Newswires) -- William P. Burke, Director, on October 29, 2025, sold 58,483 shares in Axogen ( AXGN ) for $1,246,717. Following the Form 4 filing with the SEC, Burke has control over a total of 100 common shares of the company, with 100 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/xslF345X05/wk-form4_1761941351.xml ...
Pfizer Gets Early FTC Approval for Metsera Acquisition
Pfizer Gets Early FTC Approval for Metsera Acquisition
Oct 31, 2025
04:12 PM EDT, 10/31/2025 (MT Newswires) -- Pfizer ( PFE ) said late Friday that the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Act for its proposed acquisition of Metsera ( MTSR ) . The early approval satisfies the primary U.S. regulatory requirement for the deal, which had been set to expire...
Navan Announces Closing of Initial Public Offering
Navan Announces Closing of Initial Public Offering
Oct 31, 2025
PALO ALTO, Calif.--(BUSINESS WIRE)-- Navan, Inc. ( NAVN ) , an all-in-one business travel, payments, and expense management platform, today announced the closing of its initial public offering of an aggregate of 36,924,406 shares of Class A common stock at a public offering price of $25.00 per share. The offering consisted of 30,000,000 shares of Class A common stock sold...
Csw Industrials Insider Sold Shares Worth $250,000, According to a Recent SEC Filing
Csw Industrials Insider Sold Shares Worth $250,000, According to a Recent SEC Filing
Oct 31, 2025
04:13 PM EDT, 10/31/2025 (MT Newswires) -- Joseph B Armes, Director, Chairman, President & CEO, on October 30, 2025, sold 1,000 shares in Csw Industrials ( CSW ) for $250,000. Following the Form 4 filing with the SEC, Armes has control over a total of 69,712 common shares of the company, with 66,493 shares held directly and 3,219 controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved